000039622 000__ 00895cam\a2200253\\\4500
000039622 001__ 39622
000039622 005__ 20210513011056.0
000039622 008__ 810520s1980\\\\mdua\\\\\b\\\\100\0\eng\d
000039622 010__ $$a79-600202
000039622 035__ $$a(OCoLC)ocm07434936
000039622 035__ $$a39622
000039622 037__ $$a017-012-00291-9$$bGPO
000039622 040__ $$aHNI$$cHNI$$dGPO$$dVVD$$dISE
000039622 049__ $$aISEA
000039622 050_4 $$aQR186.7$$b.I334 1979
000039622 074__ $$a475
000039622 0860_ $$aHE 20.4002:Im 6/2
000039622 24500 $$aImmunoglobulins :$$bcharacteristics and uses of intravenous preparations /$$cBarbara M. Alving, J.S. Finlayson, editors.
000039622 260__ $$a[Bethesda, Md.?] :$$bU.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration,$$c1980.
000039622 300__ $$ax, 245 p. :$$bill. ;$$c27 cm.
000039622 504__ $$aIncludes bibliographical references.
000039622 650_0 $$aImmunoglobulins$$vCongresses.
000039622 650_0 $$aIntravenous therapy$$vCongresses.
000039622 7001_ $$aAlving, Barbara M.
000039622 85200 $$bgen$$hQR186.7$$i.I334$$i1979
000039622 909CO $$ooai:library.usi.edu:39622$$pGLOBAL_SET
000039622 980__ $$aBIB
000039622 980__ $$aBOOK